GDNF, NGF and BDNF as therapeutic options for neurodegeneration.
about
Physical Activity, Air Pollution and the BrainThe Role of Current Techniques and Concepts in Peripheral Nerve RepairModulation of neurotrophic signaling pathways by polyphenolsThe involvement of BDNF, NGF and GDNF in aging and Alzheimer's diseaseLong non-coding RNA-dependent transcriptional regulation in neuronal development and diseaseThe protective role of prosaposin and its receptors in the nervous systemA review of bioactive release from nerve conduits as a neurotherapeutic strategy for neuronal growth in peripheral nerve injuryNeuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal DegenerationReleasing Nrf2 to promote neurite outgrowthUridine from Pleurotus giganteus and Its Neurite Outgrowth Stimulatory Effects with Underlying MechanismB-RAF kinase drives developmental axon growth and promotes axon regeneration in the injured mature CNSTargeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound.The temporal and spatial dynamics of glyoxalase I following excitoxicity and brain ischaemia.Low-Intensity Extracorporeal Shock Wave Therapy Enhances Brain-Derived Neurotrophic Factor Expression through PERK/ATF4 Signaling Pathway.Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness.The Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors.Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury.Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer's Disease Phase IIa and Expanded Access Trials.Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.The stem cell secretome and its role in brain repair.Naringin: a protector of the nigrostriatal dopaminergic projection.Schwann Cell Precursors from Human Pluripotent Stem Cells as a Potential Therapeutic Target for Myelin Repair.Back to the future with phenotypic screeningMidnolin is a novel regulator of parkin expression and is associated with Parkinson's DiseaseCombined effect of nerve growth factor and brain‑derived neurotrophic factor on neuronal differentiation of neural stem cells and the potential molecular mechanismsThe nerve growth factor signaling and its potential as therapeutic target for glaucomaDeficiency of GDNF Receptor GFRα1 in Alzheimer's Neurons Results in Neuronal DeathEffects of naringin, a flavanone glycoside in grapefruits and citrus fruits, on the nigrostriatal dopaminergic projection in the adult brainNeuroregeneration and dementia: new treatment options.A double-blind, rct testing beneficial modulation of BDNF in middle-aged, life style-stressed subjects: a clue to brain protection?Humoral activity of cord blood-derived stem/progenitor cells: implications for stem cell-based adjuvant therapy of neurodegenerative disorders.Chronic amitriptyline treatment attenuates nigrostriatal degeneration and significantly alters trophic support in a rat model of parkinsonismL-serine treatment may improve neurorestoration of rats after permanent focal cerebral ischemia potentially through improvement of neurorepairRoles of Rheb(S16H) in substantia nigra pars compacta dopaminergic neurons in vivoBAC-based cellular model for screening regulators of BDNF gene transcription.Tricyclic antidepressant treatment evokes regional changes in neurotrophic factors over time within the intact and degenerating nigrostriatal system.MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway.Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injuryAstrocyte-like cells differentiated from a novel population of CD45-positive cells in adult human peripheral blood.Neuronal cell cycle: the neuron itself and its circumstances
P2860
Q22337355-96F730D7-0359-4B0E-B5E7-A206B6689651Q26767350-383F5754-9001-4FBF-9688-B40B83AC7D7CQ26771195-43024A51-3A92-4602-8D29-7101ACF897B7Q26783362-AC4175D3-0D2B-48B5-A029-EBC988625737Q26999388-8D12FF46-1F02-4962-BA8B-8B29AFC7E02AQ27014092-E32BD221-C96F-43DD-8F95-2C6639DD6D40Q27027789-5C4750A5-C636-4195-92C4-2F9D5D3F9FB3Q28069477-B2607061-1C01-4431-897C-62935212414DQ28385265-8A21FE92-72BF-44BF-A288-79E68625A2B2Q28550957-BC4D52A7-2775-42B7-86EB-A0FD0F3626D9Q28589147-CDE23D71-DCC7-4B5E-812E-7CD4B12D920CQ30277809-6719328E-C8A4-46CF-95BA-9E948E4C7486Q30317490-75A6229E-7333-4F71-B6AD-4E2D01C450F8Q30360890-8C3E71DB-6F91-422C-9248-7E24BAA12504Q30411312-1BA90AFC-1141-4AB0-8280-542F1FE27C18Q30486741-10CD27C5-33A6-4DBD-9E0B-CB18FA7251FEQ30585823-C5BF7B97-4121-41AD-9B41-44A87D56ADAAQ33708951-6A40FC56-6C04-4C94-91EC-476319509C7CQ33722420-93B2528B-9E8A-4002-B01E-B4790E8128D2Q33771698-61D0C29B-5EA6-4390-BE4D-AEB59941E893Q33787324-493CD5C6-92A2-449E-8E43-28F6597C39C8Q33794697-568904DC-3EA9-4365-89B7-EC96C1A5DC8BQ33918218-2B2744AF-12EA-484F-BF94-E773642AFB76Q33918418-53EE8EE4-933A-4F07-A641-2BB53ACCA959Q34105254-CAA1F08F-4334-41F8-8B59-C0AD78AC304DQ34182180-EC0B7AED-B681-4573-AC6C-8FE1AC4AA985Q34233456-F1F9D85E-40DC-4ABA-A502-6997DAA02584Q34319584-A310384C-354C-42F3-AD50-DD42AB584B11Q34470357-D038A70E-54C4-45B5-93FB-2335D57147C9Q34910290-5CDBCAE6-1D18-4F8A-85BC-96661C914260Q35082645-310CA06F-C637-4C4B-8496-53065CF314EDQ35089378-4A5D6C4F-801B-41C4-8096-E02019DE0195Q35132210-3226210C-1119-4B71-8A47-4924934B7C72Q35180062-2AC5A75A-BF4F-4708-8B62-5A112C22EA3DQ35190887-91936192-7F18-4D0E-A729-092D6FC546CEQ35243291-2FC22140-BD82-48E9-ADA1-CAE8C5DEFFD0Q35484424-1CE24D3C-B886-4FD9-AC35-779DCCCCC2D3Q35540600-5419711E-3F7E-4CEE-AAE3-22CAD4740576Q35541178-52E53165-BB6A-41BF-AA0F-5C651C4F17B9Q35565056-32800E8D-A163-41BF-B21C-5AA9DE4A0772
P2860
GDNF, NGF and BDNF as therapeutic options for neurodegeneration.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
GDNF, NGF and BDNF as therapeutic options for neurodegeneration.
@en
type
label
GDNF, NGF and BDNF as therapeutic options for neurodegeneration.
@en
prefLabel
GDNF, NGF and BDNF as therapeutic options for neurodegeneration.
@en
P2093
P1476
GDNF, NGF and BDNF as therapeutic options for neurodegeneration
@en
P2093
Judy J Watson
Neil U Barua
Nikunj K Patel
P304
P356
10.1016/J.PHARMTHERA.2013.01.004
P577
2013-01-21T00:00:00Z